Article Sidebar
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Efficacy of a combination of Yiqi Huoxue Tongluo decoction and Chinese acupuncture in the treatment of ischemic stroke, and its effect on neurological function and activity of daily living
Abstract
Purpose: To investigate the clinical effect of combined use of Yiqi Huoxue Tongluo decoction and Chinese acupuncture on ischemic stroke, and its effect on neurological function and activity of daily living (ADL) of patients.
Methods: Three hundred and seventeen (317) ischemic stroke patients on admission at Ganzhou People's Hospital (GPH) were selected and randomly divided into acupuncture group (n = 159) and combination group (n = 158). Routine treatment of lesions was done for all patients. The acupuncture group was treated with Chinese acupuncture, while the combination group received a combination of Yiqi Huoxue Tongluo decoction and Chinese acupuncture. All treatments lasted for one month. Indicators such as clinical efficacy, neurological function and ADL were determined in each group.
Results: The combination group had significantly higher post-treatment objective response rate (ORR) than the acupuncture group (p < 0.05). The levels of growth differentiation factor-15 (GDF-15) and plasminogen activator inhibitor 1 (PAI-1) were significantly reduced in both groups, with significantly lower levels in the combination group than in acupuncture patients (p < 0.05). Varying degrees of decrease in neuropathy disability (NDS) scores were seen in both groups, and at 1 month and 3 months after treatment, the NDS scores of the combination group were lower than those of the acupuncture group (p < 0.05). Both groups had higher BI scores after treatment, but at 1 month and 3 months posttreatment, the BI scores of the combination group were significantly higher than those of the acupuncture group (p < 0.05).
Conclusion: The use of a combination of Yiqi Huoxue Tongluo decoction and Chinese acupuncture produced better clinical efficacy and lower serum evels of GDF-15 and PAI-1 than acupuncture, and it significantly improved the ADL of patients.
